bioAffinity Technologies, Inc. Income Taxes Paid
bioAffinity Technologies, Inc. (BIAF) reported Income Taxes Paid of $23.39 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-07
- bioAffinity Technologies, Inc. income taxes paid, net for the quarter ending 2025-12-31 was -$17.48K, a 393.22% decline year-over-year.
- bioAffinity Technologies, Inc. income taxes paid, net for the quarter ending 2025-09-30 was $3.18K, a 24.35% increase year-over-year.
- bioAffinity Technologies, Inc. income taxes paid, net for the quarter ending 2025-06-30 was $28.98K, a 434.86% increase year-over-year.
- bioAffinity Technologies, Inc. income taxes paid, net for the quarter ending 2025-03-31 was $8.70K, a 136.79% increase year-over-year.
- bioAffinity Technologies, Inc. income taxes paid, net for fiscal 2025 was $23.39K, a 32.79% increase from fiscal 2024.
- bioAffinity Technologies, Inc. income taxes paid, net for fiscal 2024 was $17.61K, a 16.11% decline from fiscal 2023.
- bioAffinity Technologies, Inc. income taxes paid, net for fiscal 2023 was $20.99K, a 31.48% decline from fiscal 2022.
- bioAffinity Technologies, Inc. income taxes paid, net for fiscal 2022 was $30.64K, a 1471.13% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 3 month as first filed | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 9 month as first filed | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$17.48K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$14.29K derived: sum of 2 quarters · filed 2026-03-16 | $14.69K derived: sum of 3 quarters · filed 2026-08-07 | $23.39K 10-K · filed 2026-03-16 | |||
| 2025-09-30 | $3.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $32.17K derived: sum of 2 quarters · filed 2026-08-07 | $40.86K 10-Q · filed 2025-11-14 | $46.82K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | $28.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $37.68K 10-Q · filed 2026-08-07 | $43.64K derived: sum of 3 quarters · filed 2026-08-07 | $46.20K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $8.70K 10-Q · filed 2026-05-11 | $14.65K derived: sum of 2 quarters · filed 2026-05-11 | $17.21K derived: sum of 3 quarters · filed 2026-05-11 | $22.63K derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $5.96K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $8.52K derived: sum of 2 quarters · filed 2026-03-16 | $13.94K derived: sum of 3 quarters · filed 2026-03-16 | $17.61K 10-K · filed 2026-03-16 | $11.65K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $2.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $7.98K derived: sum of 2 quarters · filed 2025-11-14 | $11.65K 10-Q · filed 2025-11-14 | $13.94K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $5.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $9.09K 10-Q · filed 2025-08-14 | $11.38K derived: sum of 3 quarters · filed 2025-08-14 | $13.68K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $3.67K 10-Q · filed 2025-05-15 | $5.96K derived: sum of 2 quarters · filed 2025-05-15 | $8.26K derived: sum of 3 quarters · filed 2025-05-15 | $23.01K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $2.29K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.59K derived: sum of 2 quarters · filed 2025-03-31 | $19.34K derived: sum of 3 quarters · filed 2025-03-31 | $20.99K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $2.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $17.05K derived: sum of 2 quarters · filed 2024-11-14 | $18.70K 10-Q · filed 2024-11-14 | $45.39K derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $14.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $16.41K 10-Q · filed 2024-08-14 | $43.10K derived: sum of 3 quarters · filed 2024-08-14 | $44.88K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $1.66K 10-Q · filed 2024-05-15 | $11.82K 10-Q · filed 2023-05-15 | $28.35K derived: sum of 2 quarters · filed 2024-05-15 | $30.13K derived: sum of 3 quarters · filed 2024-05-15 | $30.13K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $26.69K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $28.48K derived: sum of 2 quarters · filed 2024-04-01 | $28.48K derived: sum of 3 quarters · filed 2024-04-01 | $30.64K 10-K · filed 2024-04-01 | $2.46K 10-K · filed 2023-03-31 | ||
| 2022-09-30 | $1.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.79K derived: sum of 2 quarters · filed 2023-11-14 | $3.94K 10-Q · filed 2023-11-14 | $2.46K 10-Q · filed 2022-11-14 | $3.94K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.16K 10-Q · filed 2023-08-14 | $2.16K derived: sum of 3 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $2.16K 10-Q · filed 2023-05-15 | $2.16K derived: sum of 2 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.95K 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | $1.95K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |